| nodules developed on mutant roots transformed with NCR-new35 construct |
showed |
typical zonation of indeterminate nodules with colonized cells in ZIII |
Medicago truncatula |
| GA biosynthesis and catabolism gene expression |
co-occurs in |
cells undergoing infection and/or nodule development |
Glycine max; Medicago truncatula |
| ISOPENTENYLTRANSFERASE (GmIPT3) |
is expressed in |
nodule primordia |
Glycine max |
| tight regulation of CK levels |
is necessary for |
nodule maintenance |
Glycine max |
| zones of indeterminate nodules |
could be already identified in |
mutant nodules |
Medicago truncatula |
| infected cells in ZII and IZ |
exhibited similar morphology in |
mutant and WT nodules |
Medicago truncatula |
| nodules developed on NF-FN9363 roots transformed with NCR343 |
were |
functional nodules |
Medicago truncatula |
| LjHO1 mRNA level |
was upregulated during |
nodule maturation at 2 wpi |
Lotus japonicus |
| species-producing determinate nodules |
form nodules mainly from |
outer and middle cortex |
|
| Psdella mutants |
develop |
less nodules |
Pisum sativum |
| mitotic activity of meristem cells (zone I, ZI) |
produces |
new cells for all nodule tissues |
Medicago truncatula |
| LjHO2 transcript level |
did not significantly increase during |
nodule development |
Lotus japonicus |
| gibberellins (GA) |
promote |
subsequent progression of nodule development |
Pisum sativum |
| GUS expression |
was associated with |
invasion zone in 10 dpi nodules |
Medicago truncatula |
| GmINS1 RNA interference lines |
have |
33.4% lower dry weight of large nodules than empty vector control |
|
| miR4407 |
is expressed in |
nodule primordium around root pericycle region |
Glycine max |
| NCR247 knockout |
causes plants to form |
small and white nodules |
|
| nodule-like structure formation |
appears to require |
NODULE INCEPTION (NIN) |
|
| BAP (cytokinin) application to WT pea |
suppressed |
number of nodules |
Pisum sativum |
| miR4407pro-GUS signal |
is lower in |
nodule primordium |
Glycine max |
| NCR-new35 expression |
is significantly lower and limited to |
transition zone of the nodule |
Medicago truncatula |
| nodule colonization in mutants NF-FN9363, Mtsym19 and Mtsym20 |
was similar to |
nodule colonization in Medicago truncatula dnf4 and dnf7 mutants |
Medicago truncatula |
| Mtsym20 mutant |
develops |
slightly elongated white nodules with zonation |
Medicago truncatula |
| rhizobia |
secrete |
lipochitooligosaccharides (Nod factors) |
|
| MtMATE67 gene |
is expressed primarily in |
invasion zone of mature nodules |
Medicago truncatula |
| suppression of GmINS1 |
reduced |
individual nodule size |
Glycine max |
| altering the expression of GmINS1 |
significantly modified |
nodule expansion |
Glycine max |
| na CASP::NA roots |
developed similar number of mature nodules to |
WT roots |
Pisum sativum |
| miR4407 |
was found to be expressed in |
outer cortex of mature nodule |
Glycine max |
| NF-FN9363 mutant |
develops |
slightly elongated white nodules with zonation |
Medicago truncatula |
| gibberellin (GA) |
promotes |
nodule initiation via suppression of ethylene biosynthesis |
Pisum sativum |
| gibberellin (GA) and ethylene |
act relatively independently to promote |
nodule maturation |
Pisum sativum |
| auxin transport |
is reported to play key role in |
nodule organ formation |
|
| miR4407 |
was found to be expressed in |
primordium of nascent nodule |
Glycine max |
| miR4407 expression pattern |
changes during |
nodule development |
Glycine max |
| LjHO1 protein |
was abundant in |
mature nodules at 4 and 6 wpi |
Lotus japonicus |
| loss of function della mutants |
inhibits |
spontaneous nodule formation in ccamk and CK receptor gain of function mutants |
Medicago truncatula |
| vacuoles in IZ cells of mutant nodules |
remained reduced in |
IZ cells of mutant nodules |
Medicago truncatula |
| CYCLOPS expression |
was detected only in |
mature nodule at 7 and 14 dpi |
Aeschynomene evenia |
| nodule cells in nitrogen fixation zone of mutant NF-FN9363 |
were devoid of |
rhizobia |
Medicago truncatula |
| mutants missing all DELLA genes |
display |
range of nodule types |
Medicago truncatula |
| cytokinins (CK) |
promotes |
nodule organogenesis and development |
|
| white round-shaped or slightly cylindrical nodules |
were formed on |
empty vector-transformed roots of mutant plants |
Medicago truncatula |
| miR4407 |
is mainly expressed in |
cortex and vascular bundles of developing and mature nodules |
Glycine max |
| GmINS1 RNA interference lines |
have |
63.2% of nodules in large nodule group |
|
| (NLP4, AT1G20640) |
competes for binding sites on target genes with |
NIN (NODULE INCEPTION) |
Lotus japonicus |
| mature nodules in WT |
were present at |
8 dpi |
Pisum sativum |
| GmSPX5/8 |
mediate |
soybean nodule growth |
Glycine max |
| During nodule development |
the number of rhizobia in infected cells |
increases dramatically |
|
| MtMATE67 transcripts |
are detected in |
all nodule zones |
Medicago truncatula |
| three GmINS1 OX lines |
have individual nodule size increased by |
34.1%, 31.7%, and 69.6% |
|
| GmINS1 expression |
was strongly associated with |
large nodule number |
Glycine max |
| tight regulation of CK levels |
is necessary for |
nodule initiation |
Glycine max |
| auxin response |
promotes |
nodule primordia development |
Pisum sativum |
| plants with disrupted GA biosynthesis |
negatively impact |
nodule number |
Pisum sativum; Glycine max; Medicago truncatula |
| synthetic CK 6-Benzylaminopurine (BAP) |
can suppress |
nodule number |
Pisum sativum |
| P2 large nodules |
have |
22.8% higher number of infection cells than P1 |
|
| GmINS1 overexpression lines |
have |
14.7% increase in number of infection cells |
|
| overexpression of DMI2/SYMRK kinase domain |
causes |
spontaneous nodulation |
|
| altering the expression of GmINS1 |
significantly modified |
infection cell development |
Glycine max |
| overexpression of full-length SYMRK/DMI2 |
leads to |
spontaneous nodule formation |
|
| DMI2/SYMRK kinase domain overexpression |
decreases |
nodule numbers in sunn mutants |
Medicago truncatula |
| high rates of respiration by plant mitochondria and rhizobia |
contributes to |
low oxygen concentrations around rhizobia |
|
| empty vector control plants |
have |
71.9% of nodules in large nodule group |
|
| INCREASING NODULE SIZE1 (GmINS1) |
is |
critical gene in nodule development |
Glycine max |
| GmINS1 expression in soybean nodules |
directly affects |
nodule growth and development |
|
| GmINS1 expression |
was strongly associated with |
individual nodule weight |
Glycine max |
| dmi2-1 plants expressing wild-type gDMI2-HAST |
generate |
many nodules |
Medicago truncatula |
| P2 large nodules |
have |
55.7% higher surface area of 100 infection cells than P1 |
|
| GmINS1 and GmEXPB2 expression |
is associated with |
determinate nodule formation and expansion |
|
| three GmINS1 OX lines |
showed increases of |
74.7%, 87.7%, and 131.4% in nodule dry weight |
|
| GmEXPB2 expression |
is expressed preferentially in |
nodule vascular trace and nodule vascular bundle (NVB) in early stages of nodule development |
Glycine max |
| dmi2-1 plants transformed with wild-type gDMI2-HAST |
generate |
large number of pink nodules |
Medicago truncatula |
| persistent meristem of indeterminate nodules |
generates |
developmental gradient of cells |
|
| legume species |
form |
indeterminate nodules |
|
| stably transformed soybean plants with GmINS1 overexpression |
showed |
significant increases in number of large nodules |
Glycine max |
| GmINS1 expression |
significantly promoted |
nodule development and expansion |
Glycine max |
| overexpressing the kinase domain or full-length DOES NOT MAKE INFECTIONS 2 (DMI2) / SYMBIOSIS RECEPTOR KINASE (SYMRK) |
results in |
spontaneous nodulation or hypernodulation phenotype in legumes |
|
| INCREASING NODULE SIZE1 (GmINS1) overexpression |
results in increases in |
infection cell abundance |
Glycine max |
| GmINS1 overexpression lines |
have |
20.9% increase in surface area of 100 infection cells |
|
| GmINS1 overexpression |
led to |
larger infection cells |
Glycine max |
| Glyma.U014500 |
was named |
GmINS1 |
|
| GmINS1 expression |
is associated significantly with |
individual nodule weight |
Glycine max |
| GmINS1 expression |
is expressed primarily during |
rapid developing stage of nodules |
Glycine max |
| restricted gas diffusion across outer cell layers of nodule |
contributes to |
low oxygen concentrations around rhizobia |
|
| GmINS1 suppression |
leads to |
more numerous and smaller nodules compared with empty vector control |
|
| GmINS1 expression |
is localized in |
nodule vascular bundle (NVB) |
Glycine max |
| GmINS1 overexpression |
led to |
higher number of large nodules (D ≥ 2 mm) |
Glycine max |
| nodule development signaling |
enables |
plants to develop functional nodules |
Medicago truncatula |
| GUS staining |
was observed primarily in |
distal invasion zone and vascular bundles in 38 dpi nodules |
Medicago truncatula |
| determinate nodules |
lose meristematic activity very early in |
nodule development |
|
| cell expansion and cell wall extension |
might play crucial roles in |
organogenesis of determinate nodules |
|
| GmINS1 overexpression lines |
have individual nodule size |
not affected compared with control roots |
|
| soybean nodules |
are |
determinate |
Glycine max |
| nodulating plants provided with bioavailable nitrogen |
shut down |
nodules |
|
| lacZ-expressing rhizobia |
were relatively few in |
21 dpi mate67 nodules |
Medicago truncatula; Sinorhizobium meliloti |
| INCREASING NODULE SIZE1 (GmINS1) |
is expressed primarily in |
vascular bundles, cortical and parenchyma cells of nodules |
Glycine max |
| P2 large nodules |
contain |
more and larger infection cells than P1 |
|
| protein level of DMI2 |
is important for |
proper function in nodule development |
Medicago truncatula |
| indeterminate nodules |
have |
persistent meristem producing meristem zone, infection zone, interzone, fixation zone, and senescence zone |
|
| mutant nodules |
were reduced in size compared with |
WT nodules |
Medicago truncatula |
| GA application |
inhibits |
spontaneous nodule formation in ccamk and CK receptor gain of function mutants |
Medicago truncatula |
| na EXPA::NA roots |
develop |
small nodules containing reduced level of rhizobial colonisation |
Pisum sativum |
| na CASP::NA roots |
developed many more |
nodules |
Pisum sativum |
| nodule inception protein (NIN) |
is |
marker gene of early nodule development |
Medicago truncatula |
| DOES NOT MAKE INFECTIONS 2 (DMI2) protein constitutively degraded by the proteasome apparatus |
results in suppression of |
nodule development signaling pathway |
|
| GmINS1 overexpression lines |
resulted in |
67.7%, 72%, and 74.7% large nodules |
|
| double suppression of GmEXPB2 and GmINS1 |
resulted in decreases in |
size of infection cells |
Glycine max |
| oxygen concentrations around rhizobia |
plummet during |
nodule development |
|
| mate67 mutant nodules |
failed to develop |
pink color characteristic of Leghemoglobin |
Medicago truncatula |
| GmINS1 overexpression |
facilitates |
nodule expansion |
|
| MtENOD40 |
regulates |
nodule development |
Medicago truncatula |
| Medicago truncatula plants overexpressing ENOD40 |
exhibited |
accelerated nodulation |
Medicago truncatula |
| GmSPX5 overexpression |
increases |
nodule number |
Glycine max |
| abi1-1 gene introduced into Medicago truncatula |
enhanced |
Nod factor-induced gene expression |
Medicago truncatula |
| symbiosome-specific SULTR3 transporter |
was essential for |
development of functional nodules |
Lotus japonicus |
| GmEXPB2 |
participates in |
nodule development and growth |
Glycine max |
| GmINS1 |
participates in |
nodule development and growth |
Glycine max |
| GmSPX5 overexpression |
increases |
nodule fresh weight |
Glycine max |
| GmSPX5 and GmNF-YC4 |
could positively regulate |
soybean nodule development |
|
| PA level in roots |
decreases after |
4-10 days post-nodulation |
Glycine max |
| MtNF-YA1 and MtNF-YA2 |
have been implicated as regulators of |
nodulation |
Medicago truncatula |
| SL mimics |
designed to inhibit |
nodule elongation |
Pisum sativum |
| INCREASING NODULE SIZE1 (GmINS1) suppression via RNA interference |
has opposite effect on |
nodule development and plant phenotypes |
Glycine max |
| GmINS1 overexpression lines |
have |
27.6% higher number of large nodules than empty vector control |
|
| GmINS1 |
is homolog of |
GmEXPB2 |
|
| GmNF-YC4 overexpression |
significantly upregulates expression of |
GmASL2 |
Glycine max |
| phosphorus (P) deficiency |
reduces |
nodule fresh weight |
Glycine max |
| peptide hormones |
have important roles in |
nodule development |
|
| GmSPX5 and GmNF-YC4 interaction |
activates |
GmASL6 expression |
Glycine max |
| LjNOD16 mRNA synthesis in nodules |
is the result of |
transcriptional activity of a bi-directional, nodule-specific promoter located in an intron of the LjPLPIV gene |
Lotus japonicus |
| decrease in MtNoa1/ (ATNOA1, ATNOS1, NOA1, NOS1, RIF1, SVR10, AT3G47450) expression level |
significantly lowered |
nodule number |
Medicago truncatula |
| GmNF-YC4 overexpression |
significantly upregulates expression of |
GmASL4 |
Glycine max |
| GmNF-YC4 |
positively regulates |
nodule fresh weight |
Glycine max |
| GmSPX5 |
is preferentially expressed in |
nodules |
|
| overexpression of GmSPX5 |
led to significant increases of |
soybean nodule number and fresh weight, especially under phosphate sufficient conditions |
|
| overexpression of a gene encoding ureide permease (ATUPS1, UPS1, AT2G03590) |
was found to enhance |
nodule growth, accompanying a significant increase of asparagine concentration in soybean nodules |
|
| GmEXPB2 |
is predominantly expressed in |
young nodules |
Glycine max |
| GmNF-YC4 overexpression |
increases |
nodule fresh weight |
Glycine max |
| indeterminate nodules |
are initiated from |
inner cortical cells |
Medicago truncatula |
| homologous cysteine proteases |
participate in |
legume nodule development |
|
| mineral nutrient availability |
adversely affects |
nodule development and nitrogen fixation |
|
| overexpression of GmNF-YC4 |
led to significant increases of |
soybean nodule number and fresh weight, especially under phosphate sufficient conditions |
|
| actin molecular motor myosin, thin microfilaments and thicker microfilament bundles |
are found surrounding |
symbiosomes during cell division in nodules |
|
| GmSPX5 overexpression |
enhances |
soybean nodule development |
Glycine max |
| CHH hypermethylation |
is a prime feature of |
soybean nodule methylome |
Glycine max |
| GmSPX5 overexpression |
particularly enhances nodule development under |
phosphate (Pi) sufficient conditions |
Glycine max |
| auxin |
promotes |
cortical nodule organogenesis |
Medicago |
| recognition of Nod factors (NFs) by compatible LysM-type plant receptors |
leads to |
formation of root nodules |
|
| MtDMI2 |
is part of |
nodulation signalling regulation |
Medicago truncatula |
| GmPLDα4 |
shows increased expression during |
nodule development |
Glycine max |
| increased expression of GmSPX5 and its downstream genes in other soybean organs (i.e., leaves or roots) |
might be caused by |
enhanced nodule development in OX8 and OX12 lines |
|
| gain-of-function mutations of calcium and calmodulin-dependent protein kinase (CCaMK) |
result in |
spontaneous nodules |
Medicago truncatula; Lotus japonicus |
| Interzone 2–3 |
is |
narrow, amyloplast-rich cell layer |
Medicago truncatula |
| GmEXPB2 |
acts in |
nodule development and expansion |
|
| legume nodules |
have |
central infected tissue |
|
| SERK expression |
has not previously been reported in |
nodulation |
|
| nodule morphological traits |
includes |
nodule volume |
Trifolium repens L. |
| GmNF-YC4 overexpression |
significantly upregulates expression of |
GmASL3 |
Glycine max |
| GmPLDδ1 |
shows increased expression during |
nodule development |
Glycine max |
| ACTIN and TUBULIN production |
supports |
microtubule and microfilament dynamics during nodule growth and development |
Glycine max |
| GmSPX5 |
is preferentially expressed in |
soybean nodules |
Glycine max |
| MtNF-YA1 |
is required for |
nodule meristem persistence |
Medicago truncatula |
| Ljinv1 mutant nodules |
display |
normal wild-type structure |
Lotus japonicus |
| at least 25% of extant legumes |
do not have |
infection threads |
|
| actinorhizal nodules |
have |
central vascular tissue |
|
| bacteroids |
form |
symbiosome |
Medicago truncatula; Lotus japonicus |
| increase in organic acid formation per plant in +CO2 plants |
is the result of |
more nodule fresh weight per plant |
|
| nodule formation and nitrogen fixation |
are highly energy-consuming |
processes |
|
| legume nodules |
have |
peripheral vascular system |
|
| reduced N/A invertase activity |
does not affect |
ability of the plant to form functional nodules |
Lotus japonicus |
| initial event |
led to evolution of |
two branched pathways of nodule developmental processes |
|
| (ATSERK1, SERK1, AT1G71830) |
is highly expressed in |
nodules |
Medicago truncatula |
| RNAi:: MtNoa1/ (ATNOA1, ATNOS1, NOA1, NOS1, RIF1, SVR10, AT3G47450) plants |
showed strong decrease in |
nodule primordia |
Medicago truncatula |
| RNAi:: MtNoa1/ (ATNOA1, ATNOS1, NOA1, NOS1, RIF1, SVR10, AT3G47450) plants |
showed strong decrease in |
nodule number |
Medicago truncatula |
| Zone 1 |
is characterized by absence of |
rhizobia |
Medicago truncatula |
| nodule structures |
are |
host determined |
|
| Mtnf-ya1-1 mutants |
have |
delayed and reduced nodule development |
Medicago truncatula |
| high CO2 concentrations around nodules |
affects |
nodule size |
Glycine max; Pisum sativum; Phaseolus vulgaris |
| root nodules |
contain |
differentiated bacteria (bacteroids) |
|
| development of functional nodules |
depends on |
interconnected programmes for bacterial infection and de novo organ formation |
|
| nitric oxide (NO) production |
was detected in |
functional Medicago truncatula–Sinorhizobium meliloti indeterminate nodules |
Medicago truncatula; Sinorhizobium meliloti |
| na mutant |
develop few |
nodules |
Pisum sativum |
| GmIPT3 |
is expressed in |
nodule epidermis, cortex, and symbiotic region during entire nodule development |
Glycine max |
| mGmIPT3 and GmIPT3 overexpression |
promoted |
nodule formation |
Glycine max |
| this region |
is composed of a single layer of cells in |
WT nodules |
Medicago truncatula |
| host cells and rhizobia in Zone 3 |
complete differentiation processes |
differentiation processes initiated in proximal part of zone 2 |
Medicago truncatula |
| gene encoding a zinc finger protein involved in nodule organogenesis |
has been shown to be expressed in |
vascular bundles |
|
| legumes forming indeterminate nodules |
form nodules from |
inner cell layers of the root, including the inner cortex, pericycle and endodermis |
|
| complementation of nodules |
was assessed based on |
presence of rhizobia in ZIII |
Medicago truncatula |
| miR1512 |
is involved in |
nodule development |
Glycine max |
| miR396 and MtGRF targets |
are expressed in |
mature nodules |
Medicago truncatula |
| no visible difference |
was detected in |
morphology and invasion of nodule cells in distal part of ZII of WT and mutant nodules |
Medicago truncatula |
| DsRed-fluorescent transgenic Mtsym19 and Mtsym20 roots expressing gene NCR-new35 |
developed |
elongated and pink nodules |
Medicago truncatula |
| confocal and electron microscopy |
used to characterize |
nodulation phenotype |
Medicago truncatula |
| mutant plants |
developed |
roundish or slightly cylindrical white nodules |
Medicago truncatula |
| nodules developed on roots of NF-FN9363 transformed with construct of NCR343 |
were |
elongated and pink |
Medicago truncatula |
| plants with disrupted GA biosynthesis |
negatively impact in some cases |
nodule function |
Pisum sativum; Glycine max; Medicago truncatula |
| bioactive GA levels |
are elevated in |
Lotus nodule tissue compared with uninfected roots |
Lotus japonicus |
| Zone 3 |
is also called |
nodule 'central tissue' |
Medicago truncatula |
| MtNF-YA1 expression |
gradually becomes more expressed in |
apical zone |
Medicago truncatula |
| zone 2 |
is |
pre-fixation zone |
Medicago truncatula |
| MtNF-YA1 expression |
follows a gradient of decreasing intensity from |
meristematic zone down to proximal part of infection zone |
Medicago truncatula |
| chalcone synthase gene silencing |
results in strongly reduced |
nodulation |
|
| Mtnf-ya1-1 mutants |
have nodules preferentially on |
lateral roots |
Medicago truncatula |
| symbiosomes |
are |
small cytoplasmic vesicles |
Medicago truncatula |
| MtCLE12 and MtCLE13 expression patterns |
overlap from |
primordium stage onwards |
Medicago truncatula |
| nodulation inhibition |
depends on |
long-distance mechanism |
|
| MtCLE13 gain-of-function phenotype |
may be absent in |
sunn mutants |
Medicago truncatula |
| RNAi (ATUPS1, UPS1, AT2G03590) nodules |
show arrest in |
nodule development |
Glycine max |
| D1:HyP4,11 peptide |
has |
strong effects for enhancing nodulation |
Medicago truncatula |
| formation of increasingly larger nodules with higher per nodule activity |
was found |
in the experiment |
|
| MtNF-YA1 expression at base of young developing nodules |
fades in |
mature nodules |
Medicago truncatula |
| NSP proteins |
have been identified in |
both Lotus and Medicago |
Lotus japonicus; Medicago truncatula |
| miR169 |
is involved in |
nodule development |
Medicago truncatula |
| SrPI1 transcript |
accumulates at very early stages, possibly in response to |
Nod factors |
Sesbania rostrata; Azorhizobium caulinodans |
| (ATSERK1, SERK1, AT1G71830) expression |
is first in |
cortex and vascular tissue |
Medicago truncatula |
| long-term hydroponic growth with aeration of nutrient solution with ambient air |
might impair |
formation of optimally efficient nodules |
|
| MtNF-YA1 (HAP2-1) |
is |
HAP2-1 |
Medicago truncatula |
| short- and long-term CO2 concentration around nodules |
is of importance for |
formation of efficient nodules |
Medicago sativa |
| GmINS1 overexpression |
significantly facilitated |
nodule development |
Glycine max |
| pMtNF-YA1-GUS expression |
is restricted to |
distal end |
Medicago truncatula |
| AsE246 |
is specifically expressed in |
nodules |
Astragalus sinicus |
| GmINS1 RNA interference lines |
have |
12.4% decrease in number of infection cells |
|
| GmINS1 overexpression |
did not affect |
nodule formation |
Glycine max |
| MLD |
is necessary for DMI2 protein to play a fundamental role in |
nodule development at the very early stage |
Medicago truncatula |
| full-length DOES NOT MAKE INFECTIONS 2 (DMI2) / SYMBIOSIS RECEPTOR KINASE (SYMRK) protein overexpression |
generates |
spontaneous nodules without rhizobia infection |
|
| GmINS1 and GmEXPB2 double suppression lines |
have |
54% decrease in number of large nodules |
|
| biological nitrogen fixation (BNF) capacity |
is determined largely by |
rhizobial infection to produce more nodules and nodule organogenesis to form more expanded nodules |
Glycine max |
| dmi2-1 roots expressing MLD point mutants |
have |
few nodules |
Medicago truncatula |
| INCREASING NODULE SIZE1 (GmINS1) expression |
is strongly associated with |
nodule development |
Glycine max |
| strain-dependent mutual recognition between nodule cells and symbiotic rhizobia |
continues even after |
endosymbiosis is established |
Lotus japonicus; Mesorhizobium loti |
| auxin transport inhibitors |
application is sufficient to induce |
nodule-like cell division |
Lotus japonicus |
| Mt ARF16a |
is repressor-type regulator of |
rhizobia infection |
Medicago truncatula |
| Legumes in the tribes Trifolieae and Fabeae |
form |
indeterminate nodules |
|
| GmINS1 RNA interference lines |
have individual nodule size |
36.1% lower than control nodules |
|
| overexpression of intracellular kinase domain of SYMRK/DMI2 |
leads to |
spontaneous nodule formation |
|
| plants |
control nodule development through |
fine regulation of DOES NOT MAKE INFECTIONS 2 (DMI2) protein level |
|
| P2 genotype promoter |
is strongly associated with |
nodule development |
Glycine max |
| GmEXPB2 and INCREASING NODULE SIZE1 (GmINS1) |
synergistically control |
nodulation in soybean |
Glycine max |
| one pathway |
is necessary for |
cortical cell division |
Medicago truncatula |
| mature nodules |
contain |
various developmental zones |
Medicago truncatula |
| MtCLE13 |
is produced during |
nodule primordium development |
Medicago truncatula |
| tendency towards lower numbers of nodules in +CO2 treatment |
is not consistent with |
CO2 feeding accelerating development of young nodules |
|
| ethylene signaling |
plays central role in |
root-controlled restriction of nodule number |
Medicago truncatula |
| sunn mutant alleles |
are available in |
Medicago truncatula |
Medicago truncatula |
| RNAi (ATUPS1, UPS1, AT2G03590) nodules |
show smaller |
infected cells |
Glycine max |
| nodule-enhanced expression |
was markedly higher among |
TFs (92 out of 1513) than among all genes |
Medicago truncatula |
| ccamk-14 mutant |
shows delay of approximately 7 days in appearance of |
first fully colonized nodules |
Lotus japonicus |
| roots with modified miR396 activity |
showed |
no obvious defect on nodule density, morphology or cellular organization |
Medicago truncatula |
| PvNOD-41 |
is present exclusively in |
nodule uninfected cells |
Phaseolus vulgaris |
| 48 h post-inoculation (hpi) |
is |
time of root hair curling and the initiation of cortical cell divisions |
|
| prSERK1::GUS expression |
is investigated during |
formation of nitrogen-fixing root nodules |
Medicago truncatula |
| LHK1 |
negatively regulates |
bacterial infection |
Lotus japonicus |
| NBCL genes in indeterminate nodules |
repress |
root identity of the nodule vascular meristem (NVM) |
|
| ectopic expression of MtCLE13 |
inhibited nodulation on main untransformed roots of |
wild-type plants |
Medicago truncatula |
| sunn-4 |
is |
much stronger allele than sunn-1 |
Medicago truncatula |
| MtCLE12 |
is induced upon |
nodulation |
Medicago truncatula |
| ectopic expression of MtCLE13 |
strongly suppressed nodulation in |
skl mutant |
Medicago truncatula |
| vacuole extension |
was less pronounced in |
nodules of FN9363, Mtsym20 and Mtsym19 |
Medicago truncatula |
| differentiated bacteroids |
were oriented towards |
large vacuoles |
Medicago truncatula |
| Mtsym19 and Mtsym20 nodules |
show activation of |
second transcriptome-switch characteristic of late Fix- mutant plants |
Medicago truncatula |
| DELLA genes |
expression is elevated in |
nodule tissue |
Medicago truncatula |
| GmINS1 and GmEXPB2 double suppression lines |
have |
53.5% decrease in nodule dry weight |
|
| ABA |
can regulate |
nodulation in Lotus japonicus and M. truncatula |
Lotus japonicus; Medicago truncatula |
| GmPLDζ1 |
shows increased expression during |
nodule development |
Glycine max |
| nodules formed on legume roots |
are classified into |
indeterminate or determinate nodules |
|
| bacteroids in apn1 nodules |
appeared less dense than |
bacteroids in wild-type nodules |
Lotus japonicus |
| Ljnbcl1 NVB identity |
is lost during |
homeosis |
Lotus japonicus |
| cells leaving the meristem |
have |
fourfold haploid DNA content (4C) |
Medicago truncatula |
| gibberellins (GA) |
interact with |
auxin and cytokinins (CK) |
Pisum sativum |
| gibberellin (GA) |
play a positive role in |
nodule organogenesis and development |
|
| nodules in na mutant |
are not mature and have limited function compared with |
WT nodules |
Pisum sativum |
| bacterial invasion of ZIII in nodules developed on NF-FN9363 roots transformed with NCR343 |
was like in |
WT |
Medicago truncatula |
| lateral root primordium |
is |
region where nodule primordium will be formed |
Glycine max |
| white undeveloped nodules with colonized cells by rhizobia in ZII and IZ |
were detected on |
roots transformed with empty vector or with genes NCR341, NCR344 and NCR345 |
Medicago truncatula |
| cells in first layer of nitrogen fixation zone |
showed similar morphology in |
WT and all mutant nodules |
Medicago truncatula |
| GA produced in the endodermis |
promote |
nodule organogenesis |
Pisum sativum |
| developing nodules in WT |
were not observed until |
6 dpi |
Pisum sativum |
| knockout of LjHO1 by CRISPR/Cas9 |
resulted in disappearance of |
green nodules (GN) |
Lotus japonicus |
| RNA interference of GmINS1 alone |
had similar effects to |
double suppression of GmEXPB2 and GmINS1 |
Glycine max |
| miR4407 |
is never expressed in |
symbiotic region during whole nodule development process |
Glycine max |
| abi1-1 gene introduced into Medicago truncatula |
enhanced |
hyper-nodulation phenotype |
Medicago truncatula |
| (MIR172C, AT3G11435) expression |
starts to drop at 14 dpi and continues to diminish up to 28 dpi |
nodulation time course |
Glycine max |
| rhizobia-infected nodule cells |
were observed in |
infection zone and interzone of mutant nodules |
Medicago truncatula |
| indeterminate nodules |
possess |
persistent meristem during lifespan |
Medicago truncatula |
| mutant nodules |
did not contain infected cells in |
region corresponding to mature nitrogen fixation zone of WT nodules |
Medicago truncatula |
| na mutants during time course |
had no developing or mature nodules observed |
developing or mature nodules |
Pisum sativum |
| debino1 mutant |
forms |
small and white nodules |
Medicago truncatula |
| extension of this part of nodules |
indicates |
arrest of further differentiation of infected nodule cells |
Medicago truncatula |
| plants with disrupted GA biosynthesis |
negatively impact |
nodule size |
Pisum sativum; Glycine max; Medicago truncatula |
| nodule senescence |
occurs at |
late stage of development (nodule aging) |
|
| LjHO1 mRNA level |
was upregulated in |
mature nodules at 4 and 6 wpi |
Lotus japonicus |
| high CK levels and CK-responsive gene expression |
are localised in |
developing pea nodules |
Pisum sativum |
| nodules on roots of mutants transformed with modified NCRs |
were |
small and white |
Medicago truncatula |
| indeterminate nodules |
are derived in part from |
lateral root programme |
|
| GA |
promote |
nodule organogenesis and nodule development in inner root layers |
Pisum sativum |
| nitrate |
inhibits |
nodule initiation |
|
| reduced number of infections |
likely due to |
Psdella mutants develop less nodules |
Pisum sativum |
| cytokinins (CK) |
seems to be required for |
subsequent auxin accumulation during nodule organogenesis |
|
| CLE-RS2 |
works as negative regulator of |
nodule formation |
Lotus japonicus |
| discontinuity between rhizobia and plant cell walls |
was observed in |
proximal part of IZ and ZIII of mutant nodules |
Medicago truncatula |
| small and white nodules |
suggested |
malfunctioning nodules |
Medicago truncatula |
| (MIR166, MIR166G, AT5G63715) |
is involved in |
nodule development |
Medicago truncatula |
| mtr-miR396a promoter activity |
is primarily detected in |
nodule vascular tissues |
Medicago truncatula |
| mtr-miR396a promoter activity |
shows weak staining in |
nitrogen-fixing region (zone III) |
Medicago truncatula |
| (anac094, NAC094, AT5G39820) overexpression |
results in decreased |
red nodule numbers |
Lotus japonicus |
| nitrogen deficiency of ineffective symbiotic mutants |
induced |
increased number of nodules |
Medicago truncatula |
| nodules on roots of mutants transformed with modified NCRs |
did not show |
typical zonation of indeterminate nodules |
Medicago truncatula |
| MtGRF4 and MtGRF5 expression patterns |
partly overlap with |
miR396 expression pattern |
Medicago truncatula |
| nodulation-related CLE peptides |
may restrict |
nodulation |
Medicago truncatula |
| soybeans |
develop |
spherical, determinate nodules |
Glycine max |
| NF-YA/ (GCS1, HAP2, AT4G11720) and NF-YC/ (ATCCC1, CCC1, HAP5, AT1G30450) |
are required for |
nodule organogenesis |
|
| NOOT-BOP-COCH-LIKE (NBCL) functions |
are conserved in |
both indeterminate and determinate nodules |
|
| GRAS transcription factors (ATMLP-470, ATNSP1, NSP1, AT3G16400) and (ATNSP2, NSP2, AT2G33070) |
are required for |
rhizobia infection and nodule organogenesis |
Lotus japonicus; Medicago truncatula |
| indeterminate nodules |
possess |
nodule central meristem (NCM) |
|
| CO2 feeding |
may accelerate |
development of young nodules |
|
| Mtnf-ya1-1 mutant |
has 4.6-fold fewer nodules than |
A17 at 5 dpi |
Medicago truncatula |
| rate of nodulation and amount of nodule tissue per root |
showed no significant difference in |
three of the four combinations of plants and rhizobia tested |
Medicago; Sinorhizobium meliloti |
| WT nodules |
showed |
characteristic zonation of indeterminate nodules colonized with rhizobia |
Medicago truncatula |
| senescence and defence response-specific marker genes |
can be distinguished based on activation of |
defence-reactions and premature senescence-related autofluorescence |
Medicago truncatula |
| simultaneous knockdown of MtCLE12 and MtCLE13 |
enhanced |
number of nodules |
Medicago truncatula |
| ABA |
suppresses |
organogenesis at nodule development stage |
|
| increased microtubular cytoskeleton |
is observed in |
initial nodule primordium with dividing cells in rhizobium-infected roots |
|
| GmSPX5 overexpression |
significantly upregulates expression of |
GmASL2 |
Glycine max |
| phosphate (Pi) starvation |
inhibits |
nodulation in legume plants |
|
| mobile auxin signal |
coordinates |
infection with nodule organogenesis |
Medicago |
| MtMATE67 transcript levels |
are very low in |
wild-type roots before inoculation |
Medicago truncatula |
| GmINS1 RNA interference lines |
have |
20.7% lower number of large nodules than empty vector control |
|
| GmINS1 suppression |
significantly inhibits |
nodule development |
|
| TE7 mutant |
is defective in |
IPD3 gene |
Medicago truncatula |
| DOES NOT MAKE INFECTIONS 2 (DMI2) / SYMBIOSIS RECEPTOR KINASE (SYMRK) kinase domain overexpression |
generates |
spontaneous nodules without rhizobia infection |
|
| ENOD40 npcRNA family |
is involved in |
formation of symbiotic nitrogen-fixing nodules |
|
| GmNF-YC4 overexpression |
increases |
nodule number |
Glycine max |
| mitotic reactivation of differentiated root cortex cells |
forms |
nodule primordium |
|
| MtKNOX3 and MtKNOX5 genes |
were unexpectedly upregulated in |
cluster #2 48 h after rhizobium inoculation |
Medicago truncatula |
| nodule apical meristematic cells |
differentiate into |
central symbiotic fate cells |
Medicago truncatula |
| scRNA-seq profiling with novel techniques |
provides |
wealth of data for understanding precise architecture of indeterminate nodules |
Medicago truncatula |
| linking high-resolution single-cell data with spatial information |
may be critical to answering |
questions about nodule development |
Medicago truncatula |
| SUPER NUMERIC NODULES (SUNN) |
functions in |
shoot regulation of nodule numbers |
Medicago truncatula |
| GmINS1 and GmEXPB2 double suppression lines |
have |
38.2% reduction in surface area of 100 infection cells |
|
| nbcl mutants |
are characterized by |
emergence of root-like structures from the nodule vascular meristem (NVM) |
|
| untransformed roots of complemented plants |
produced only |
white nodules |
Medicago truncatula |
| transgenic composite soybean lines with double suppression of GmEXPB2 and GmINS1 |
severely inhibited |
soybean nodulation |
Glycine max |
| Chinese milk vetch (Astragalus sinicus) |
forms |
indeterminate-type N2-fixing root nodules |
Astragalus sinicus |
| sunn mutants |
display |
supernodulation phenotype |
Medicago truncatula |
| GmINS1 overexpression |
significantly affects |
nodule morphological development |
|
| NIN (NODULE INCEPTION) |
is essential for |
nodule organogenesis |
Lotus japonicus |
| NAC094-overexpressing plants (NAC-OE1 and NAC-OE2) |
exhibit increased |
nodule numbers |
Lotus japonicus |
| gibberellins (GA) |
are required for |
normal auxin activation during nodule primordia formation |
Pisum sativum |
| expression of a della dominant active protein |
induces |
spontaneous nodule-like structures |
Medicago truncatula |
| AsE246 |
is |
specific to nodulation |
Astragalus sinicus |
| MLD |
is vital for |
proper function of DMI2 regarding sufficient nodule development |
Medicago truncatula |
| GUS expression |
was not associated with |
nitrogen-fixation zone in 10 dpi nodules |
Medicago truncatula |
| GmEXPB2 and GmINS1 |
have distinctive divisions of functions in |
initiation and development of nodules |
Glycine max |
| EARLY NODULIN11 (ENOD11) |
is |
marker gene of early nodule development |
Medicago truncatula |
| stabilized DOES NOT MAKE INFECTIONS 2 (DMI2) |
initiates |
nodule development signaling |
Medicago truncatula |
| determinate nodules |
are derived from |
cell divisions in outer root cortex |
|
| GmINS1 RNA interference lines |
have |
21.5% decrease in surface area of 100 infection cells |
|
| GmEXPB2 |
was most abundantly expressed in |
nodules at 7 days after inoculation |
Glycine max |
| DMI2/SYMRK kinase domain or full-length DMI2/SYMRK protein overexpression |
can induce |
spontaneous nodulation phenotype |
legume plants |
| roots expressing gDMI2-HAST versions with amino acid substitutions in MLD |
generate |
very few pink nodules |
Medicago truncatula |
| GmINS1 overexpression lines |
have |
91.9% of nodules in large nodule group |
|
| DMI2 C39D point mutation |
results in |
no nodules |
Medicago truncatula |
| developmental gradient of cells |
forms |
invasion zone (II) |
|
| MtMATE67 transcript levels |
increase steadily after inoculation with rhizobia between 2 and 8 dpi |
rhizobia inoculation |
Medicago truncatula |
| GmINS1 overexpression lines |
have |
20.9% higher dry weight of large nodules than empty vector control |
|
| Does Not fix Nitrogen 2 (MtDNF2) |
was upregulated in |
cluster #2 48 h after rhizobium inoculation |
Medicago truncatula |
| NP |
may serve as |
connections between more differentiated clusters |
Medicago truncatula |
| leghemoglobin |
binding and rapid delivery of oxygen contributes to |
low oxygen concentrations around rhizobia |
|
| INCREASING NODULE SIZE1 (GmINS1) overexpression |
results in increases in |
nodule biomass |
Glycine max |
| GmINS1 expression level |
is |
important contributor to the nodulation QTL |
Glycine max |
| legume plants growing in environments with abundant nitrogen |
do not make |
nodules despite the presence of rhizobia |
|
| double RNA interference of GmINS1 and GmEXPB2 |
significantly inhibits |
nodule development |
|
| induction of root cortical cell division |
establishes |
meristem and nodule primordium |
|
| three GmINS1 OX lines |
showed increases of |
62.5%, 62.6%, and 66.9% in number of large nodules |
|
| GmINS1 expression |
is localized mainly within |
nodule cortex and parenchymatous cells |
Glycine max |
| GmINS1 |
might play |
dominant role in nodule enlargement |
Glycine max |
| GmEXPB2 and GmINS1 |
coordinately control |
soybean nodulation |
Glycine max |
| developmental gradient of cells |
forms |
senescence zone (IV) |
|
| GUS staining |
was observed in |
nodule primordium at 4 dpi |
Medicago truncatula |
| lipochitooligosaccharides (Nod factors) |
initiate |
nodule development |
|
| Lotus japonicus LjMATE1 |
is expressed in |
nodule-specific manner |
Lotus japonicus |
| wild-type plants |
showed |
60.7% large nodules |
|
| suppression of GmINS1 |
reduced |
number of infection cells |
Glycine max |
| two β-expansin proteins (GmEXPB2 and GmINS1) |
might coordinately regulate |
soybean nodulation |
Glycine max |
| root identity |
is acquired during |
homeosis |
Lotus japonicus |
| GmEXPB2 transcripts |
are most abundant in |
early stages of nodule development |
Glycine max |
| developmental gradient of cells |
forms |
meristem (zone I) |
|
| GmINS1 expression |
is associated significantly with |
number of large nodules |
Glycine max |
| irregularly shaped infected cells stained deeply with toluidine blue |
had lost |
turgor pressure |
Lotus japonicus |
| (NLP4, AT1G20640) |
controls |
nodule number |
Lotus japonicus |
| indeterminate nodules |
consist of |
developmental gradient of cells forming distinct zones |
Medicago truncatula |
| nodules developed on empty vector-transformed WT roots |
showed |
typical zonation of indeterminate nodules with colonized cells in ZIII |
Medicago truncatula |
| Mtsym19 mutant |
develops |
slightly elongated white nodules with zonation |
Medicago truncatula |
| nodules |
may produce |
gibberellin (GA) |
Pisum sativum |
| apn1 mutants |
form |
small and dark brown or black nodules |
Lotus japonicus; Mesorhizobium loti |
| APN1 |
may play role(s) in |
nodule development even with compatible Mesorhizobium loti strains |
Lotus japonicus; Mesorhizobium loti |
| auxin transport inhibitors |
application is sufficient to induce |
nodulin genes |
Lotus japonicus |
| mtr-miR396b promoter activity |
is high in |
vascular tissues, infection zone (zone II) and upper parts of fixation zone (zone III) |
Medicago truncatula |
| extension of this part of nodules |
was observed in |
all mutants |
Medicago truncatula |
| nodule regions proximal to root corresponding to ZIII |
were devoid of |
bacteria |
Medicago truncatula |
| overaccumulated DOES NOT MAKE INFECTIONS 2 (DMI2) protein |
can activate |
nodule development signaling pathway without the presence of rhizobia |
|
| GmINS1 and GmEXPB2 double suppression lines |
have |
33.4% decrease in individual nodule size |
|
| CK transported from the epidermis to the cortex |
promotes |
nodule organogenesis |
Medicago truncatula |
| MicroRNA 4407 (miR4407) |
is expressed in |
nodule primordia |
Glycine max |
| rhizobia-colonized cells |
were observed only in |
zones II and IZs of nodules formed on empty vector-transformed Mtsym19 and Mtsym20 roots |
Medicago truncatula |
| Psdella mutants |
display |
normal size and function nodules |
Pisum sativum |
| flavonoid biosynthesis |
plays important role as |
signaling molecules in nodule development |
Medicago truncatula |
| apn1 nodules |
developed |
infected cells filled with bacteroids |
Lotus japonicus |
| some infected cells of apn1 nodules at 8 dpi |
were |
swollen with irregularly shaped symbiosomes and lytic vacuoles |
Lotus japonicus |
| auxin signalling |
has recently been identified as regulator of |
rhizobia infection |
Medicago truncatula |
| LjNBCL1 |
functions in |
maintenance of determinate nodule identity |
Lotus japonicus |
| elongation zone |
is |
region of the root most susceptible to nodulation |
Medicago truncatula |
| heterotrimeric NF-Y complex |
regulates |
nodule differentiation |
Lotus japonicus; Medicago truncatula |
| NOOT-BOP-COCH-LIKE (NBCL) genes |
are required for |
maintaining the identity of indeterminate nitrogen-fixing nodules with persistent meristems |
|
| single-cell/nucleus analysis |
identifies responses within |
tissues and complex organs |
Medicago truncatula |
| biomass of individual nodules |
shows no differences between wild-type and Mtpin2 mutants after |
3 weeks |
Medicago truncatula |
| Medtr8g037170 |
is |
MtMATE67 |
Medicago truncatula |
| suppression of GmINS1 |
limited |
nodule enlargement |
Glycine max |
| roots expressing gDMI2-HAST versions with amino acid substitutions in MLD |
are impaired in |
nodule development |
Medicago truncatula |
| mate67 mutant nodules |
were smaller than |
wild-type nodules from 10 dpi onwards |
Medicago truncatula |
| members of large family of NCR genes |
are activated in |
successive waves during nodule differentiation |
Medicago truncatula |
| CK produced in the epidermis |
may enhance |
nodule development in the cortex |
|
| excessive nodule development |
disturbs |
host growth |
|
| legume species |
form |
determinate nodules |
|
| GUS staining |
was detected within |
dividing cells of the nodule primordium |
Medicago truncatula |
| double suppression of GmEXPB2 and GmINS1 |
resulted in decreases in |
number and weight of large nodules |
Glycine max |
| indeterminate-type N2-fixing root nodules |
consist of |
gradient of developmental zones with persistent apical meristem (zone I), infection zone (zone II), and fixation zone (zone III) |
Astragalus sinicus |
| accumulated DOES NOT MAKE INFECTIONS 2 (DMI2) |
induces |
plant roots to start nodule development |
Medicago truncatula |
| protein level of DOES NOT MAKE INFECTIONS 2 (DMI2) / SYMBIOSIS RECEPTOR KINASE (SYMRK) |
is |
master determinate signal of nodule development |
|
| MtMATE67 transcripts |
have peak expression in |
invasion zone |
Medicago truncatula |
| soybeans |
produce |
determinate nodules |
Glycine max |
| GmINS1 |
functions primarily in |
nodule development |
Glycine max |
| 34:3, 34:2, 36:5 and 36:4 PA |
accounts for increase in |
PA content in nodules |
Glycine max |
| actin and tubulin cytoskeleton-related gene expression |
change markedly during |
root–rhizobium interactions and nodule development |
Glycine max |
| GmINS1 |
acts in |
nodule development and expansion |
|
| Medicago truncatula plants silenced for ENOD40 |
form |
only a few and modified nodule-like structures |
Medicago truncatula |
| balance between ABA and Nod factor concentrations |
is |
important factor in nodulation |
|
| bacterial partner |
is delivered and released into |
symbiosomes within plant nodule cells |
|
| differentiation trajectory of these clusters |
consistent with |
well-known successive developmental process of symbiotic components |
Medicago truncatula |
| scRNA-seq profiling |
generates |
refined spatial and functional cellular map |
Medicago truncatula |
| miR1515 |
is involved in |
nodule development |
Glycine max |
| INCREASING NODULE SIZE1 (GmINS1) overexpression |
results in increases in |
nodule number |
Glycine max |
| GmEXPB2 and INCREASING NODULE SIZE1 (GmINS1) double suppression |
dramatically inhibits |
soybean nodulation |
Glycine max |
| GmINS1 |
functions especially during |
enlargement of nodules and infection cells |
Glycine max |
| nodule development signaling pathway activation without the presence of rhizobia |
leads to |
spontaneous nodulation phenotype |
|
| developmental gradient of cells |
forms |
nitrogen-fixation zone (III) |
|
| MtMATE67 transcript levels |
reach levels 15-fold higher than in 0 dpi roots |
0 dpi roots |
Medicago truncatula |
| apical meristem of indeterminate nodules |
develops into |
continuous differentiated zones |
|
| marker genes of NF1 and NF2 |
indicates function along with |
appearance of nitrogen fixation zone |
Medicago truncatula |
| NP |
serves as |
connection |
Medicago truncatula |
| GmSACPD-A, GmSACPD-B, and GmSACPD-D mutants |
do not affect |
nodule development and structure |
|
| mutations in GmSACPD-A, GmSACPD-B, and GmSACPD-D |
increase seed stearic acid content without affecting |
nodule development |
Glycine max |
| high expression of GmSACPD-C in nodules |
is in agreement with |
observed cell senescence and necrotic cavity in the Gmsacpd-c mutants |
Glycine max |
| bacteria to infect the root tissue |
allows bacteria to reach |
developing nodule |
|
| actinorhizal nodules |
have |
peripheral infected tissue |
|
| indeterminate nodules |
maintain |
meristem throughout their life cycle |
Medicago truncatula |
| Zone 3 |
is |
fixation zone |
Medicago truncatula |
| GAs and (AtCKS, CKS, KDSB, AT1G53000) |
have antagonistic functions during |
nodule organogenesis |
Medicago truncatula |
| In mature nodules |
a senescence zone (zone IV) is established |
proximal to zone III |
Astragalus sinicus |
| MtMATE67 gene |
is induced early during |
nodule development |
Medicago truncatula |
| GmINS1 and GmEXPB2 double suppression lines |
have |
14.7% fewer infection cells |
|
| nodule organogenesis |
incorporates |
nodule formation, differentiation, and maturation |
|
| stably transformed soybean plants with GmINS1 overexpression |
showed |
significant increases in individual nodule size |
Glycine max |
| Trx h in soybean roots |
is required during |
nodule development |
Glycine max |
| Pi starvation |
decreases |
total nodule fresh weight |
Glycine max |
| differentiation of nodule cells |
is one of |
primary processes involved in nodule development |
|
| Medicago truncatula root tip |
provides basis to explore |
nodule development and function |
Medicago truncatula |
| GmSACPD-C deleterious mutations |
result in |
nodule cell senescence |
Glycine max |
| tropical legume Sesbania rostrata |
has |
versatile nodulation features |
Sesbania rostrata |
| rapid reorganization of the actin cytoskeleton |
is observed in |
initial nodule primordium with dividing cells in rhizobium-infected roots |
|
| GmSPX5 overexpression |
significantly upregulates expression of |
GmASL3 |
Glycine max |
| GmSPX5 overexpression |
significantly upregulates expression of |
GmASL4 |
Glycine max |
| LjNF-YA1 |
has been implicated as regulator of |
nodulation |
Lotus japonicus |
| various cell types |
lead to creation of |
functional nodule capable of supporting nitrogen fixation |
|
| major disruption of iron, copper, or zinc delivery to nodules |
results in |
reduction in nodule size |
Medicago truncatula |
| one branched pathway of nodule developmental processes |
involves |
development of infection threads |
|
| GmNF-YC4 overexpression |
significantly upregulates expression of |
GmASL6 |
Glycine max |
| LjNF-YA1 |
was observed to participate in nodule formation by targeting genes encoding |
Short Internodes/stylish transcription factors ( (AtSTY1, SRS1, STY1, AT3G51060) (SRS2, STY2, AT4G36260) and STY3) |
Lotus japonicus |
| PLDα1 transcript levels |
change markedly during |
root–rhizobium interactions and nodule development |
Glycine max |
| 34:2 and 36:2 PC and PE |
accounts for increase in |
PC and PE content in nodules |
Glycine max |
| GmNF-YC4 overexpression |
significantly upregulates expression of |
GmASL5 |
Glycine max |
| GmSPX5 |
interacts with |
GmNF-YC4 |
Glycine max |
| GmSPX5 overexpression |
significantly upregulates expression of |
GmASL5 |
Glycine max |
| Pi starvation |
inhibits |
soybean nodule biomass |
Glycine max |
| GmSPX5 |
positively regulates |
nodule fresh weight |
Glycine max |
| GmSPX5 and GmNF-YC4 |
control transcription of |
group of downstream genes in soybean nodules |
Glycine max |
| division of nodule cells |
is crucial for |
root nodule development |
|
| DNA methylation dynamics |
occurs during |
nodule development |
Medicago truncatula |
| NCR169 |
is essential for |
development of nitrogen-fixing nodules |
Medicago truncatula |
| GmSPX5–GmNF-YC4–GmASL6 regulatory pathway |
is present in |
soybean nodules |
|
| GmEXPB2 expression |
improves |
nodulation regardless of phosphorus availability |
Glycine max |
| various mutations of Gmsacpd-a, Gmsacpd-b, and Gmsacpd-d |
were analyzed for their effect on |
nitrogen-fixing nodules |
Glycine max |
| each type of nodule |
may show |
determinate growth |
|
| actinorhizal nodules |
differs structurally from |
legume nodules |
|
| Pi starvation |
decreases |
individual nodule fresh weight |
Glycine max |
| bi-directional, nodule-specific promoter located in an intron of the LjPLPIV gene |
generates |
nodule-specific antisense transcripts of the region encoding an N-terminal (ATSEC14, SEC14, AT4G39180) domain |
Lotus japonicus |
| differentiation of nodule cells |
is crucial for |
root nodule development |
|
| some Medicago truncatula Fix– mutants |
resemble |
Ljapn1 in nodule phenotypes |
Medicago truncatula; Lotus japonicus |